吸引＆生検針の世界市場予測（～2024年）...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Market Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Research Approach
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 End User-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 31)
4.1 Aspiration and Biopsy Needles Market Overview
4.2 Aspiration and Biopsy Needles Market Share, By Product
4.3 Aspiration and Biopsy Needles Market, By End User, 2019 Vs. 2024 (USD Million)
4.4 Aspiration and Biopsy Needles Market, By Procedure, 2019 Vs. 2024 (USD Million)
4.5 Aspiration and Biopsy Needles Market, By Site, 2019 Vs. 2024 (USD Million)
4.6 Aspiration and Biopsy Needles Market, By Region
5 Market Overview (Page No. – 34)
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Rising Prevalence of Cancer
5.1.1.2 Cancer Awareness Initiatives Undertaken By Governments and Global Health Organizations
5.1.1.3 Increasing Preference for Minimally Invasive Biopsies
5.1.2 Restraints
5.1.2.1 Risk of Infections Associated With the use of Aspiration and Biopsy Needles
5.1.3 Opportunities
5.1.3.1 Emerging Economies
5.1.4 Challenges
5.1.4.1 Underdeveloped Healthcare Infrastructure and Dearth of Well-Trained Radiologists and Oncologists
5.2 Industry Trends
5.2.1 Emergence of Liquid Biopsy
6 Aspiration and Biopsy Needles Market, By Product (Page No. – 39)
6.1 Introduction
6.2 Biopsy Needles
6.2.1 Biopsy Needles Market Split, By Site, 2017–2024 (USD Million)
6.2.2 Biopsy Needles Market Split, By Procedure, 2017–2024 (USD Million)
6.2.3 Biopsy Needles Market Split, By End User, 2017–2024 (USD Million)
6.2.4 CNB Needles
6.2.4.1 Low Procedural Costs, Accuracy, and Rapidity of Core Needle Biopsy Procedures Will Drive Demand for Associated Needles
6.2.5 CNB Needles Market Split, By Site, 2017–2024 (USD Million)
6.2.6 CNB Needles Market Split, By Procedure, 2017–2024 (USD Million)
6.2.7 CNB Needles Market Split, By End User, 2017–2024 (USD Million)
6.2.8 VAB Needles
6.2.8.1 High Diagnostic Specificity of Vacuum-Assisted Biopsy is Likely to Drive Market Growth
6.2.9 VAB Needles Market Split, By Site, 2017–2024 (USD Million)
6.2.10 VAB Needles Market Split, By Procedure, 2017–2024 (USD Million)
6.2.11 VAB Needles Market Split, By End User, 2017–2024 (USD Million)
6.3 Aspiration Needles
6.3.1 Low Accuracy and the Possibility of False-Positive Results Have Hindered the Adoption of Aspiration Needles
6.3.2 Aspiration Needles Market Split, By Site, 2017–2024 (USD Million)
6.3.3 Aspiration Needles Market Split, By Procedure, 2017–2024 (USD Million)
6.3.4 Aspiration Needles Market Split, By End User, 2017–2024 (USD Million)
7 Aspiration and Biopsy Needles Market, By Procedure (Page No. – 51)
7.1 Introduction
7.2 Image-Guided Procedures
7.2.1 Ultrasound
7.2.1.1 Ultrasound is Gradually Becoming the Most Important Adjunctive Imaging Modality for Cancer Diagnosis
7.2.2 Stereotactic
7.2.2.1 Stereotactic-Guided Biopsy Can Evaluate Tiny Masses Which are Not Visible Through Ultrasound
7.2.3 Mri
7.2.3.1 High Cost, Limited Reimbursement, and Lengthy Procedure—Key Factors Restraining the Market Growth
7.2.4 Other Image-Guided Procedures
7.3 Nonimage-Guided Procedures
7.3.1 Nonimage-Guided Procedures are Majorly Performed in Superficial Areas of Suspicious Abnormality
8 Aspiration and Biopsy Needles Market, By Site (Page No. – 59)
8.1 Introduction
8.2 Breast
8.2.1 Increasing Awareness of Breast Cancer to Drive the Growth of This Market Segment
8.3 Lung
8.3.1 Growing Prevalence of Lung Cancer to Support the Growth of This Market Segment
8.4 Colorectal
8.4.1 Advancements in Alternative Diagnosis Techniques to Reduce the Adoption of Colorectal Biopsy Needles
8.5 Prostate
8.5.1 Availability of Funds for Prostate Cancer Research By Different Government Authorities to Support the Growth of This Market Segment
8.6 Kidney
8.6.1 Rising Prevalence of Kidney Cancer to Support the Growth of This Market Segment
8.7 Bone and Bone Marrow
8.7.1 Rising Incidence of Bone Cancer Across the Globe to Drive the Growth of This Market Segment
8.8 Other Sites
9 Aspiration and Biopsy Needles Market, By Region (Page No. – 68)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the North American Aspiration and Biopsy Needles Market Primarily Due to a Large Number of Diagnostic Imaging Procedures Performed in the Country
9.2.2 Canada
9.2.2.1 Rising Prevalence of Cancer is Supporting the Adoption of Aspiration and Biopsy Needles in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 High Healthcare Spending and Per Capita Healthcare Spending in the Country to Support Market Growth
9.3.2 UK
9.3.2.1 Growing Awareness and Support for Cancer-Related Activities are Propelling the Growth of the Aspiration and Biopsy Needles Market in the Country
9.3.3 France
9.3.3.1 France to Register the Highest Growth in the European Aspiration and Biopsy Needles Market
9.3.4 Rest of Europe
9.4 APAC
9.4.1 Japan
9.4.1.1 Presence of a Well-Developed Healthcare System, Coupled With the Availability of a Universal Healthcare Reimbursement Policy, is Aiding the Growth of the Aspiration and Biopsy Needles Market in Japan
9.4.2 China
9.4.2.1 Rising Prevalence of Cancer and the Growing Spending Capacity of the Middle-Class Population to Drive the Market for Aspiration and Biopsy Needles in China
9.4.3 India
9.4.3.1 Presence of a Large Patient Population and Growing Access to Healthcare Facilities to Support Market Growth
9.4.4 Rest of Asia Pacific
9.5 Rest of World (RoW)
10 Competitive Landscape (Page No. – 99)
10.1 Introduction
10.2 Market Ranking Analysis
10.3 Competitive Scenario
10.3.1 Product Launches and Approvals
10.3.2 Acquisitions
10.4 Competitive Leadership Mapping
10.4.1 Competitive Leadership Mapping: Major Market Players (2017)
10.4.1.1 Visionary Leaders
10.4.1.2 Innovators
10.4.1.3 Dynamic Players
10.4.1.4 Emerging Companies
11 Company Profiles (Page No. – 103)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Argon Medical Devices, Inc.
11.2 Becton, Dickinson and Company (BD)
11.3 Boston Scientific Corporation
11.4 Cardinal Health, Inc.
11.5 CONMED Corporation
11.6 Cook Group Incorporated
11.7 HAKKO CO.,LTD Medical Device Division
11.8 INRAD Inc.
11.9 Medtronic, Plc
11.10 Merit Medical Systems
11.11 Olympus Corporation
11.12 Ranfac Corporation
11.13 Remington Medical Inc.
11.14 Somatex Medical Technologies
11.15 Stryker Corporation
*Business Overview, Products Offered, Recent Developments, MnM View Might Not be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 127)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details